Pure Global

BNP Rapid Quantitative Test - India CDSCO Medical Device Registration

BNP Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000278_18ea8695f1ca43e02adfbbf8add089af_cf7ef3ba6b3d632abbdd27f40ba3d025. The license holder is RAPID DIAGNOSTIC PVT. LTD., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
BNP Rapid Quantitative Test
UID: IMP/IVD/2020/000278_18ea8695f1ca43e02adfbbf8add089af_cf7ef3ba6b3d632abbdd27f40ba3d025

Device Class

Class C

Approving Authority

CDSCO

Product Information

Intended for quantitative determination of Brain Natriuretic Peptides ##PLACEHOLDER_0## in human whole blood or plasma. This test is used as an aid to predict the risk of heart failure

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing